Do you suffer from hypertriglyceridemia?
This clinical research study is looking at the safety and effectiveness of a medication for people with hypertriglyceridemia and atherosclerotic cardiovascular disease, or with severe hypertriglyceridemia.
Would you like to contribute to medical research?
As a volunteer in a research study, you’ll receive study-related medical care from the study doctor and regular follow-up of your condition to monitor the effectiveness of the care you’ll receive. The results of this research will be used to find out if the investigational medication being studied will be of benefit to others with hypertriglyceridemia, and whether it will be made widely available to all patients with hypertriglyceridemia. Study volunteers are an important part of moving medical care forward.
You may qualify to participate in this study if you:
- Fall into 1 of the following groups (a or b):
a. Hypertriglyceridemia with fasting TG ≥200 mg/dL (2.26 millimoles per liter [mmol/L]) and <500 mg/dL (5.65 mmol/L) with either
- Clinical diagnosis of atherosclerotic cardiovascular disease (ASCVD) OR
- At increased risk for ASCVD
b. Severe hypertriglyceridemia with fasting TG ≥500 mg/dL (5.65 mmol/L)
- Should be on standard of care (SOC) lipid-lowering medications per local guidelines. Lipid-lowering medications should be optimized and stabilized for at least 4 weeks prior to Screening to minimize changes in these medications during the study.
There are other eligibility requirements that the study doctor will review. Only the study doctor can finally determine whether you are eligible to participate in the study or not.